GlassScriptPhysician profile
John H Franklin
NPI 1225074925
$4,778.45
in general payments reported to CMS, 2019-2025
32 companies · $60.14 in 2025
The $60.14 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,896 · 2020: $155 · 2021: $179 · 2022: $175 · 2023: $177 · 2024: $136 · 2025: $60.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,352.73 | 2019 | |
| Zimmer Biomet Holdings, INC. | $158.66 | 2019-2022 | |
| Innovation Technologies INC | $149.78 | 2023 | Irrisept |
| Smith+Nephew, INC. | $135.89 | 2024 | Evos, Evos Mini |
| Conformis, INC. | $116.39 | 2019-2020 | |
| Heraeus Medical, LLC. | $116.10 | 2019-2022 | |
| Depuy Synthes Sales INC. | $110.37 | 2019-2025 | Monovisc, Orthovisc |
| Ferring Pharmaceuticals INC. | $77.73 | 2019-2022 | |
| Si-Bone, INC. | $47.33 | 2020-2021 | |
| Dynasplint Systems INC. | $38.62 | 2019 | |
| Ermi LLC | $37.37 | 2019-2025 | |
| Convatec INC. | $33.30 | 2019-2021 | |
| Amgen INC. | $32.33 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $29.56 | 2021-2022 | |
| Bioventus LLC | $29.11 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $28.04 | 2025 | |
| Anika Therapeutics, INC. | $26.89 | 2023 | Sportsmed Portfolio, Avp |
| Boston Scientific Corporation | $26.48 | 2019-2020 | |
| Baudax Bio INC. | $26.44 | 2020-2021 | |
| Acelrx Pharmaceuticals, INC. | $25.15 | 2019-2020 | |
| Medacta USA, INC. | $24.20 | 2022 | |
| Orthogenrx INC. | $20.98 | 2021 | |
| Novo Nordisk INC | $16.14 | 2020 | |
| Abbvie INC. | $15.16 | 2022 | |
| Heron Therapeutics, INC. | $14.84 | 2021 | |
| Horizon Therapeutics Plc | $14.82 | 2021 | |
| Avanos Medical | $13.28 | 2022 | |
| Intrinsic Therapeutics | $12.97 | 2022 | |
| Abbott Laboratories | $12.82 | 2022 | |
| Kci USA, INC. | $12.12 | 2022 | |
| Fidia Pharma USA INC. | $11.69 | 2019 | |
| Endo Pharmaceuticals INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.